Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...
Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System ...
Alpharetta, Ga.-based Provista Diagnostics, a clinical diagnostics lab owned by medical diagnostics company Todos Medical, cleared all necessary hurdles to begin producing its new respiratory test ...
AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) ...
QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
SANTA FE SPRINGS, Calif., December 22, 2025--(BUSINESS WIRE)--Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback